Miscellaneous recommendations
On this page you will find our recommendations sorted by BNF chapter.
Appraisal Reports are available to stakeholders on request.
Where a decision is >24 months old; these are highlighted in red. If you are a clinician working within the NTAG region and would like to prioritise an old decision for re-review please contact the professional secretary on nuth.nyrdtc.rxsupp@nhs.net
| Title | Documents | Decision | Date | |
|---|---|---|---|---|
| NENC Clinical Commissioning Policy Baricitinib for patients hospitalised due to COVID-19 (adults and children aged 2 years and over) | NENC Clinical Commissioning Policy Baricitinib for patients hospitalised due to COVID-19 (adults and children aged 2 years and over) - reviewed Oct 2025 | Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee | 09/10/2025 | |
| NTAG Decision Summary - Biosimilars statement - June 2022 | Recommendation | Recommended | 07/06/2022 | |
|
New 10/04/2025 |
North East and North Cumbria Do Not Prescribe List | North East and North Cumbria Do Not Prescribe List - Approved Nov2025 | Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee | 10/04/2025 |